Literature DB >> 15484345

Can magnetic resonance imaging predict circumferential margins and TNM stage in rectal cancer?

Graham Branagan1, Helen Chave, Clare Fuller, Shaun McGee, Derek Finnis.   

Abstract

INTRODUCTION: This study was designed to assess whether preoperative magnetic resonance imaging scans were able to predict 1) pathologic tumor and node stage, and 2) those patients with a pathologically clear circumferential resection margin.
METHODS: Patients with histologically proven carcinoma of the rectum were staged preoperatively using magnetic resonance imaging. Histologic specimens from patients undergoing mesorectal excision were reported according to the Royal College of Pathologists minimum dataset. Agreement between radiologic staging of tumor, local lymph nodes and circumferential resection margin involvement, and pathologic reporting was assessed by means of the Kappa statistic.
RESULTS: After exclusions (10 radiotherapy, 3 failed scans, 10 no surgery, 9 local surgery), 40 patients remained. Magnetic resonance imaging correctly staged the tumor in 20 patients, understaged in 12, and overstaged in 8. Statistically, there was poor correlation between pathologic and radiologic tumor staging (Kappa, 0.18; 95 percent confidence interval, -0.13 to 0.42). Magnetic resonance imaging correctly staged node status in 27 patients, overstaged in 9, and understaged in 4. Statistically, there was poor correlation between pathologic and radiologic node staging (Kappa, 0.38; 95 percent confidence interval, 0.08-0.64). Magnetic resonance imaging correctly reported the status of the circumferential resection margin in 39 patients and understaged 1. Statistically, there was good correlation between pathologic and radiologic reporting of circumferential resection margin involvement (Kappa, 0.66; 95 percent confidence interval, 0.03-1).
CONCLUSIONS: Preoperative magnetic resonance imaging scans provide poor predictive data as to subsequent pathologic tumor and node stage. Preoperative magnetic resonance imaging does produce reliable prediction of clear circumferential resection margins and provides valuable information in assessing whether patients can proceed to surgery without the need for preoperative radiotherapy.

Entities:  

Mesh:

Year:  2004        PMID: 15484345     DOI: 10.1007/s10350-004-0594-z

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

1.  Preoperative evaluation of the depth of anal canal invasion in very low rectal cancer by magnetic resonance imaging and surgical indications for intersphincteric resection.

Authors:  Yoshiko Bamba; Michio Itabashi; Shingo Kameoka
Journal:  Surg Today       Date:  2011-11-11       Impact factor: 2.549

2.  Modified neoadjuvant short-course radiation therapy in uT3 rectal carcinoma: low local recurrence rate with unchanged overall survival and frequent morbidity.

Authors:  Rainer Kube; Henry Ptok; David Jacob; Jörg Fahlke; Pawel Mroczkowski; Hans Lippert; Gunther Ziegenhardt; Uwe Schmidt; Ingo Gastinger
Journal:  Int J Colorectal Dis       Date:  2009-10-31       Impact factor: 2.571

3.  Circumferential resection margin (CRM) positivity after MRI assessment and adjuvant treatment in 189 patients undergoing rectal cancer resection.

Authors:  G S Simpson; N Eardley; F McNicol; P Healey; M Hughes; P S Rooney
Journal:  Int J Colorectal Dis       Date:  2014-03-22       Impact factor: 2.571

4.  Preoperative staging of rectal carcinoma by endorectal ultrasound: is there a learning curve?

Authors:  S A Badger; P B Devlin; P J D Neilly; R Gilliland
Journal:  Int J Colorectal Dis       Date:  2007-02-09       Impact factor: 2.571

5.  Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.

Authors:  Paul Hermanek; Susanne Merkel; Rainer Fietkau; Claus Rödel; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2009-12-10       Impact factor: 2.571

6.  Rectal cancer staging.

Authors:  James S Wu
Journal:  Clin Colon Rectal Surg       Date:  2007-08

7.  SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.

Authors:  R García-Carbonero; R Vera; F Rivera; E Parlorio; M Pagés; E González-Flores; C Fernández-Martos; M Á Corral; R Bouzas; F Matute
Journal:  Clin Transl Oncol       Date:  2016-05-20       Impact factor: 3.405

8.  Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis.

Authors:  Rebecca I Hartman; Connie Y Chang; Jennifer Y Wo; Jonathan D Eisenberg; Theodore S Hong; Mukesh G Harisinghani; G Scott Gazelle; Pari V Pandharipande
Journal:  Acad Radiol       Date:  2012-09-02       Impact factor: 3.173

9.  Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review.

Authors:  Michael R Torkzad; Lars Påhlman; Bengt Glimelius
Journal:  Insights Imaging       Date:  2010-08-15

10.  Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer.

Authors:  Jessica A Smith; Aaron T Wild; Aatur Singhi; Siva P Raman; Haoming Qiu; Rachit Kumar; Amy Hacker-Prietz; Ralph H Hruban; Ihab R Kamel; Jonathan Efron; Elizabeth C Wick; Nilofer S Azad; Luis A Diaz; Yi Le; Elwood P Armour; Susan L Gearhart; Joseph M Herman
Journal:  Int J Surg Oncol       Date:  2012-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.